Cargando…
MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas
SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the seventh most common cancer type and accounts for more than 80% of all renal tumors. Nevertheless, prognostic biomarkers for RCC are still missing. Therefore, we analyzed a large, multicenter cohort including the three most common RCC subtypes (clear...
Autores principales: | Erlmeier, Franziska, Sun, Na, Shen, Jian, Feuchtinger, Annette, Buck, Achim, Prade, Verena M., Kunzke, Thomas, Schraml, Peter, Moch, Holger, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Walch, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996951/ https://www.ncbi.nlm.nih.gov/pubmed/35406537 http://dx.doi.org/10.3390/cancers14071763 |
Ejemplares similares
-
The synergism of spatial metabolomics and morphometry improves machine learning‐based renal tumour subtype classification
por: Prade, Verena M., et al.
Publicado: (2022) -
A simple preparation step to remove excess liquid lipids in white adipose tissue enabling improved detection of metabolites via MALDI-FTICR imaging MS
por: Wang, Qian, et al.
Publicado: (2022) -
De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry
por: Prade, Verena M., et al.
Publicado: (2020) -
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome
por: Kunzke, Thomas, et al.
Publicado: (2017) -
Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma
por: Sun, Na, et al.
Publicado: (2021)